|
EIF4G2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.47230000413501E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.03450001290406E-09 |
| Normal-vs-Stage2 |
4.389800E-02 |
| Normal-vs-Stage3 |
4.014600E-01 |
| Normal-vs-Stage4 |
8.258800E-03 |
| Stage1-vs-Stage2 |
2.631600E-01 |
| Stage1-vs-Stage3 |
8.102600E-03 |
| Stage1-vs-Stage4 |
8.259600E-01 |
| Stage2-vs-Stage3 |
3.423200E-01 |
| Stage2-vs-Stage4 |
3.519800E-01 |
| Stage3-vs-Stage4 |
1.051620E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.41160005485386E-09 |
| Normal-vs-AfricanAmerican |
5.554900E-04 |
| Normal-vs-Asian |
2.745200E-01 |
| Caucasian-vs-AfricanAmerican |
4.329600E-01 |
| Caucasian-vs-Asian |
5.745200E-01 |
| AfricanAmerican-vs-Asian |
7.833800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.12080353279021E-11 |
| Normal-vs-Female |
2.801800E-01 |
| Male-vs-Female |
8.15570000000099E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.079510E-03 |
| Normal-vs-Extreme_Weight |
5.42129674485636E-11 |
| Normal-vs-Obese |
7.998500E-04 |
| Normal-vs-Extreme_Obese |
1.922200E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.207630E-01 |
| Normal_Weight-vs-Obese |
5.897400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.632800E-01 |
| Extreme_Weight-vs-Obese |
1.343610E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.248200E-01 |
| Obese-vs-Extreme_Obese |
3.282400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.579400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.17869999999953E-05 |
| Normal-vs-Age(61-80Yrs) |
7.24169946231257E-10 |
| Normal-vs-Age(81-100Yrs) |
1.056060E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.744200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.201400E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.903800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.543900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.560600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.615000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.62959687147691E-11 |
| Normal-VS-Type2 PRCC |
1.157010E-04 |
| Normal-VS-KIRP CIMP |
2.526800E-01 |
| Normal-VS-Unclassified PRCC |
4.426100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.603380E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.35049999999237E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
3.003900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.502800E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.911600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.877700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.51720000007849E-07 |
| Normal-vs-N1 |
8.126000E-01 |
| Normal-vs-N2 |
2.581400E-01 |
| N0-vs-N1 |
2.379200E-03 |
| N0-vs-N2 |
9.982200E-01 |
| N1-vs-N2 |
2.372000E-01 |
|
|
